Patent Information

    • DRAMP ID

    • DRAMP17244

    • Sequence

    • TPRLPSSADVEF

    • Sequence Length

    • 12

    • Sequence Name

    • Sequence 4 from Patent US 20060122119

    • Source

    • Homo sapiens

    • SMILES

    • CC(C)C[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)[C@@H](C)O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(C)C

    • Activity

    • Antitumor

    • Patent Type

    • Patent Application

    • Publication Date

    • 2006-6-8

    • Patent Title

    • Peptides for use in antitumor immunotherapy.

    • Abstract

    • The invention concerns the use of immunogenic peptides representing T epitopes presented by the MHC I, derived from Melan-A, MAGE-A6, gp 100, tyrosinase and NY-ESO-1 antigens for the diagnosis or treatment of melanomas in HLA-B35 subjects.